Extracellular matrix-induced changes in expression of cell cycle-related proteins and proteasome components in endometrial adenocarcinoma cells

Gynecologic Oncology

Volumn 102, Issue 3, 2006, Pages 546-551

  Koistinen, Hannu ^a   Seppälä, Markku ^a   Knuutila, Sakari ^b   Koistinen, Riitta ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Basement membrane; Cell cycle; Endometrial adenocarcinoma; Extracellular matrix; Glycodelin; Proteasome

Indexed keywords

CELL CYCLE PROTEIN; COMPLEMENTARY DNA; GROWTH PROMOTOR; MATRIGEL; PROTEASOME;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CARCINOMA CELL; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENDOMETRIUM CARCINOMA; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ADENOCARCINOMA; CELL CYCLE PROTEINS; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; ENDOMETRIAL NEOPLASMS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LAMININ; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOGLYCANS; TUMOR CELLS, CULTURED;

EID: 33748634063     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.01.028     Document Type: Article

References (34)

1. Balda M.S., and Matter K. Epithelial cell adhesion and the regulation of gene expression. Trends Cell Biol. 13 6 (2003) 310-318
2. Arnold J.T., Lessey B.A., Seppala M., and Kaufman D.G. Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells. Cancer Res. 62 1 (2002) 79-88
3. Bissell M.J., and Radisky D. Putting tumours in context. Nat. Rev., Cancer 1 1 (2001) 46-54
4. Ingber D.E. Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation 70 9-10 (2002) 547-560
5. Li M.L., Aggeler J., Farson D.A., Hatier C., Hassell J., and Bissell M.J. Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 84 1 (1987) 136-140
6. Kenny P.A., and Bissell M.J. Tumor reversion: correction of malignant behavior by microenvironmental cues. Int. J. Cancer 107 5 (2003) 688-695
7. Kleinman H.K., and Martin G.R. Matrigel: basement membrane matrix with biological activity. Semin. Cancer Biol. 15 5 (2005) 378-386
8. Kleinman H.K., McGarvey M.L., Liotta L.A., Robey P.G., Tryggvason K., and Martin G.R. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21 24 (1982) 6188-6193
9. Lin C.Q., and Bissell M.J. Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J. 7 9 (1993) 737-743
10. Hopfer H., Rinehart Jr. C.A., Kaufman D.G., and Vollmer G. Basement membrane induced differentiation of HEC-1B(L) endometrial adenocarcinoma cells affects both morphology and gene expression. Biochem. Cell. Biol. 74 2 (1996) 165-177
11. Strunck E., and Vollmer G. Variants of integrin beta 4 subunit in human endometrial adenocarcinoma cells: mediators of ECM-induced differentiation?. Biochem. Cell. Biol. 74 6 (1996) 867-873
12. Tan M.I., Strunck E., Scholzen T., Gerdes J., and Vollmer G. Extracellular matrix regulates steady-state mRNA levels of the proliferation associated protein Ki-67 in endometrial cancer cells. Cancer Lett. 140 1-2 (1999) 145-152
13. Sherman M.E. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod. Pathol. 13 3 (2000) 295-308
14. Salvesen H.B., and Akslen L.A. Molecular pathogenesis and prognostic factors in endometrial carcinoma. APMIS 110 10 (2002) 673-689
15. Inoue M. Current molecular aspects of the carcinogenesis of the uterine endometrium. Int. J. Gynecol. Cancer 11 5 (2001) 339-348
16. Nishida M. The Ishikawa cells from birth to the present. Hum. Cell 15 3 (2002) 104-117
17. Koistinen H., Seppala M., Nagy B., Tapper J., Knuutila S., and Koistinen R. Glycodelin reduces carcinoma-associated gene expression in endometrial adenocarcinoma cells. Am. J. Obstet. Gynecol. 193 6 (2005) 1955-1960
18. Koistinen H., Koistinen R., Kamarainen M., Salo J., and Seppala M. Multiple forms of messenger ribonucleic acid encoding glycodelin in male genital tract. Lab. Invest. 76 5 (1997) 683-690
19. Koistinen H., Seppala M., and Koistinen R. Different forms of insulin-like growth factor-binding protein-3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies. Clin. Chem. 40 4 (1994) 531-536
20. Birgersdotter A., Sandberg R., and Ernberg I. Gene expression perturbation in vitro-A growing case for three-dimensional (3D) culture systems. Semin. Cancer Biol. 15 5 (2005) 405-412
21. Juliano R.L. The role of beta 1 integrins in tumors. Semin. Cancer Biol. 4 5 (1993) 277-283
22. Weaver V.M., Petersen O.W., Wang F., Larabell C.A., Briand P., Damsky C., et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137 1 (1997) 231-245
23. Evan G.I., and Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411 6835 (2001) 342-348
24. Hulleman E., and Boonstra J. Regulation of G1 phase progression by growth factors and the extracellular matrix. Cell. Mol. Life Sci. 58 1 (2001) 80-93
25. Assoian R.K., and Zhu X. Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr. Opin. Cell Biol. 9 1 (1997) 93-98
26. Murray A.W. Recycling the cell cycle: cyclins revisited. Cell 116 2 (2004) 221-234
27. Serrano M. The tumor suppressor protein p16INK4a. Exp. Cell Res. 237 1 (1997) 7-13
28. Galaktionov K., Lee A.K., Eckstein J., Draetta G., Meckler J., Loda M., et al. CDC25 phosphatases as potential human oncogenes. Science 269 5230 (1995) 1575-1577
29. Garner-Hamrick P.A., and Fisher C. Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent antiproliferative effects. Int. J. Cancer 76 5 (1998) 720-728
30. Wu W., Slomovitz B.M., Celestino J., Chung L., Thornton A., and Lu K.H. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas. Cancer Res. 63 19 (2003) 6195-6199
31. Robbins B.A., de la Vega D., Ogata K., Tan E.M., and Nakamura R.M. Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch. Pathol. Lab. Med. 111 9 (1987) 841-845
32. Bureau J.P., Henry L., Baz A., Scherrer K., and Chateau M.T. Prosomes (proteasomes) changes during differentiation are related to the type of inducer. Mol. Biol. Rep. 24 1-2 (1997) 57-62
33. Bell S.E., Mavila A., Salazar R., Bayless K.J., Kanagala S., Maxwell S.A., et al. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J. Cell Sci. 114 Pt 15 (2001) 2755-2773
34. Adams J. The proteasome: a suitable antineoplastic target. Nat. Rev., Cancer 4 5 (2004) 349-360